跳至主要内容
临床试验/jRCTs061180067
jRCTs061180067已完成不适用

BNCT phaseI / II clinical trial for recurrent head and neck malignancies (BNCT for H & N malignancies)

未提供0 个研究点目标入组 40 人开始时间: 2017年9月7日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
40
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Single Arm Study
干预模型
Single Assignment
主要目的
Treatment Purpose
盲法
Open(masking Not Used)

入排标准

年龄范围
16age old over 至 85age old under(—)
性别
All

入选标准

  • With recurrence head and neck melanoma that surgical treatment is not indicated.
  • The depth of tumor, less than 6cm, and without distant metastases.
  • T/N ratio is more than 2.5 using 18F-BPA-PET.
  • KPS>= 60 percentage
  • Serum creatinine<=1.2mg/dl(male), 1.0mg/dl(female)

排除标准

  • Double cancer with disease-free period less than 3 years
  • Distant metastases
  • Active infection
  • Adverse events mere than Grade 3 induced by previous therapy
  • Tumor exposure to the skin and tumor invasion to the carotid artery
  • Severe heart complications
  • Difficulty of patient fixation for irradiation
  • White blood cell<=3000/mm3, Platelet<=100,000/mm3
  • Unsuitable patients for medical or social situation

结局指标

主要结局

-

Tumor response in 6 months after BNCT

次要结局

未报告次要终点

研究者

发起方
未提供

相似试验